Ischemia and Bleeding on the Horns of a Dilemma: Do Only Hard Endpoints Count?

J Am Coll Cardiol. 2018 Jul 10;72(2):137-140. doi: 10.1016/j.jacc.2018.04.056.

Authors

Eugenia Nikolsky¹, Freek W A Verheugt²

Affiliations

¹ Department of Cardiology, Rambam Health Care Campus and Technion-Israel Institute of Technology, Haifa, Israel. Electronic address: e_nikolsky@rambam.health.gov.il.
² Department of Cardiology, Heartcenter, Onze Lieve Vrouwe Gasthuis Ziekenhuis, Amsterdam, the Netherlands.

PMID: 29976286
DOI: 10.1016/j.jacc.2018.04.056

No abstract available

Keywords: bleeding; hard endpoints; ischemia; rivaroxaban.

Publication types

Editorial
Comment

MeSH terms

Acute Coronary Syndrome*
Factor Xa Inhibitors
Hemorrhage
Humans
Rivaroxaban*

Substances

Factor Xa Inhibitors
Rivaroxaban